GLP-1 and Ozempic are not the same thing, but they’re closely related. GLP-1 is a hormone your body makes naturally, while Ozempic is a brand-name medication designed to mimic that hormone. Think of it this way: GLP-1 is something your gut produces every time you eat, and Ozempic is a drug that copies what GLP-1 does, only in a longer-lasting, more powerful form.
What GLP-1 Does in Your Body
GLP-1 (short for glucagon-like peptide-1) is a hormone produced mainly by cells in your small intestine. When you eat a meal, your gut releases GLP-1, and it kicks off a chain of events that help manage your blood sugar. It triggers your pancreas to release insulin, which moves sugar out of your bloodstream and into your cells for energy. At the same time, it blocks another hormone called glucagon that would otherwise raise your blood sugar further.
GLP-1 also slows down how quickly food leaves your stomach, which means sugar enters your bloodstream more gradually after a meal. And it acts on parts of your brain involved in hunger, making you feel fuller sooner and for longer. These combined effects make GLP-1 one of the body’s key tools for blood sugar regulation and appetite control.
The catch is that natural GLP-1 breaks down in your body within minutes. It does its job and disappears quickly, which limits how much impact it can have on its own, especially in someone whose blood sugar regulation is already impaired.
Where Ozempic Fits In
Ozempic is one specific brand-name drug in a class called GLP-1 receptor agonists. Its active ingredient is semaglutide, made by the pharmaceutical company Novo Nordisk. The word “agonist” just means it binds to the same receptors in your body that natural GLP-1 would, triggering the same effects: more insulin when blood sugar is high, less glucagon, slower digestion, and reduced appetite.
The key difference from natural GLP-1 is durability. Semaglutide was engineered from the native GLP-1 structure but modified so it lasts far longer in the body. That’s why Ozempic is a once-weekly injection rather than something you’d need every few minutes. You inject it on the same day each week, at any time of day, with or without food. If you miss a dose, you can take it within five days; after that, you skip it and pick up on your regular schedule.
Ozempic Is One of Many GLP-1 Drugs
When people say “GLP-1” in casual conversation, they often mean the entire class of GLP-1 receptor agonist medications, not just the hormone. Ozempic is the most well-known, but it’s far from the only option. Other drugs in this class include:
- Wegovy (also semaglutide, but at higher doses and approved for weight management)
- Rybelsus (semaglutide in pill form)
- Trulicity (dulaglutide)
- Victoza (liraglutide)
- Mounjaro and Zepbound (tirzepatide, which targets both GLP-1 and another hormone receptor)
- Byetta and Bydureon (exenatide)
All of these work by mimicking natural GLP-1, but they differ in dosing, how they’re taken, what they’re approved for, and their side effect profiles. Saying “I’m on a GLP-1” could mean any of these medications.
What Ozempic Is Approved to Treat
Ozempic is FDA-approved for two main purposes: improving blood sugar control in adults with Type 2 diabetes (alongside diet and exercise), and reducing the risk of major cardiovascular events like heart attack, stroke, or death in adults with Type 2 diabetes and known heart disease. A January 2025 label update also added kidney health benefits for adults with Type 2 diabetes and chronic kidney disease.
Ozempic is not approved for weight loss, even though many people lose weight on it. That distinction belongs to Wegovy, which contains the same active ingredient (semaglutide) but at a higher maximum dose: 2.4 mg per week for Wegovy versus 2 mg for Ozempic. Research suggests the higher dose in Wegovy produces more significant weight loss, which is one reason the FDA approved it specifically for weight management in adults and children 12 and older.
Side Effects and Safety Considerations
Because Ozempic mimics GLP-1’s effect of slowing stomach emptying, the most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These tend to be worst when starting the medication or increasing the dose, which is why prescribers typically begin at a low dose (0.25 mg weekly) and increase gradually.
In some people, the slowed digestion can be more severe. Ozempic is not recommended for people with severe gastroparesis, a condition where the stomach already empties too slowly. A recent label update also flagged a concern for anyone facing surgery: because GLP-1 drugs slow digestion, food can remain in the stomach longer than expected even after fasting. There have been rare reports of patients aspirating (inhaling stomach contents) during procedures requiring general anesthesia. If you’re taking Ozempic and have a surgery or procedure scheduled, let your medical team know beforehand.
Why the Confusion Exists
The mix-up between GLP-1 and Ozempic is partly a media problem. Ozempic became a cultural phenomenon, and “GLP-1” became shorthand for the entire drug class in headlines and social media. When someone asks “are you on GLP-1?” they almost always mean one of the medications, not the hormone itself. And because Ozempic is the most recognized brand, many people use “GLP-1” and “Ozempic” interchangeably, even when they might actually be talking about Wegovy, Mounjaro, or another drug entirely.
The simplest way to keep it straight: GLP-1 is a natural hormone. GLP-1 receptor agonists are the drug class that copies it. Ozempic is one specific product within that class, prescribed primarily for Type 2 diabetes and cardiovascular risk reduction.